Section 811 (Authority to add, remove, or reschedule drugs)
GPTKB entity
Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:United_States_federal_law
|
| gptkbp:appliesTo |
controlled substances
|
| gptkbp:basisFor |
scientific evidence
medical evaluation accepted medical use potential for abuse public health risk safety under medical supervision |
| gptkbp:codifiedIn |
gptkb:21_U.S.C._§_811
|
| gptkbp:dateEnacted |
1970
|
| gptkbp:enables |
rulemaking procedures for drug scheduling
|
| gptkbp:enforcedBy |
gptkb:Drug_Enforcement_Administration
|
| gptkbp:grantsAuthorityTo |
gptkb:United_States_Senator
|
| https://www.w3.org/2000/01/rdf-schema#label |
Section 811 (Authority to add, remove, or reschedule drugs)
|
| gptkbp:legalProcess |
notice and comment rulemaking
public hearing |
| gptkbp:partOf |
gptkb:Controlled_Substances_Act
|
| gptkbp:requiresConsultationWith |
gptkb:Secretary_of_Health_and_Human_Services
|
| gptkbp:subject |
drug removal from schedules
drug rescheduling drug scheduling |
| gptkbp:bfsParent |
gptkb:Controlled_Substances_Act
|
| gptkbp:bfsLayer |
5
|